BMY vs MRK
Bristol Myers Squibb Co. and Merck & Co. Inc., side by side — 10 fiscal years reported in USD, drawn from SEC filings.
Most recent reported year
| Metric | BMY | MRK |
|---|---|---|
| Revenue | $48.2B | $65.0B |
| Net income | $7.1B | $18.3B |
| Gross margin | 71.1% | 74.8% |
| Net margin | 14.6% | 28.1% |
| Return on equity | 40.5% | 36.9% |
| Diluted EPS | $3.46 | $7.28 |
| Dividend / share | $2.49 | $3.28 |
| Payout ratio | 71.5% | 44.8% |
| Free cash flow | $12.8B | $12.4B |
| Equity | $18.5B | $52.6B |
| Net debt / equity | 1.87× | 0.66× |
| Current ratio | 1.26× | 1.54× |
| Revenue CAGR 5y | 2.5% | 9.4% |
| Profit CAGR 5y | · | 20.9% |
MRK bills 1.3× the revenue of BMY, and keeps more of each dollar of revenue as profit (28.1% against 14.6%).
The stronger figure of the pair is set in bold. That is arithmetic, not a recommendation — this page does not pick a winner. "·" marks a figure not available in our data.
10 years side by side
| Fiscal year | BMY | MRK |
|---|---|---|
| FY2025 | $48.2B | $65.0B |
| FY2024 | $48.3B | $64.2B |
| FY2023 | $45.0B | $60.1B |
| FY2022 | $46.2B | $59.3B |
| FY2021 | $46.4B | $48.7B |
| FY2020 | $42.5B | $41.5B |
| FY2019 | $26.1B | $39.1B |
| FY2018 | $22.6B | $42.3B |
| FY2017 | $20.8B | $40.1B |
| FY2016 | $19.4B | $39.8B |
Bottom line
| Fiscal year | BMY | MRK |
|---|---|---|
| FY2025 | $7.1B | $18.3B |
| FY2024 | $-8.9B | $17.1B |
| FY2023 | $8.0B | $365.0M |
| FY2022 | $6.3B | $14.5B |
| FY2021 | $7.0B | $13.0B |
| FY2020 | $-9.0B | $7.1B |
| FY2019 | $3.4B | $9.8B |
| FY2018 | $4.9B | $6.2B |
| FY2017 | $1.0B | $2.4B |
| FY2016 | $4.5B | $3.9B |
19 fiscal years
| Fiscal year | Difference | Ahead |
|---|---|---|
| FY2025 | −$16,817,000,000 | MRK |
| FY2024 | −$15,868,000,000 | MRK |
| FY2023 | −$15,109,000,000 | MRK |
| FY2022 | −$13,124,000,000 | MRK |
| FY2021 | −$2,319,000,000 | MRK |
| FY2020 | +$1,000,000,000 | BMY |
| FY2019 | −$12,976,000,000 | MRK |
| FY2018 | −$19,733,000,000 | MRK |
| FY2017 | −$19,346,000,000 | MRK |
| FY2016 | −$20,380,000,000 | MRK |
| FY2015 | −$22,938,000,000 | MRK |
| FY2014 | −$26,358,000,000 | MRK |
| FY2013 | −$27,648,000,000 | MRK |
| FY2012 | −$29,646,000,000 | MRK |
| FY2011 | −$26,803,000,000 | MRK |
| FY2010 | −$26,503,000,000 | MRK |
| FY2009 | −$8,620,000,000 | MRK |
| FY2008 | −$6,135,000,000 | MRK |
| FY2007 | −$8,580,700,000 | MRK |
The higher-revenue side has changed between BMY and MRK over this period. The gap has widened since the earliest year compared.
19 of 19 comparable fiscal years — a year missing data on either side is not counted.
19 fiscal years
| Fiscal year | Difference | Ahead |
|---|---|---|
| FY2025 | −13.5 pp | MRK |
| FY2024 | −45.2 pp | MRK |
| FY2023 | +17.2 pp | BMY |
| FY2022 | −10.8 pp | MRK |
| FY2021 | −11.7 pp | MRK |
| FY2020 | −38.2 pp | MRK |
| FY2019 | −11.8 pp | MRK |
| FY2018 | +7.3 pp | BMY |
| FY2017 | −1.3 pp | MRK |
| FY2016 | +13.3 pp | BMY |
| FY2015 | −1.4 pp | MRK |
| FY2014 | −15.5 pp | MRK |
| FY2013 | +5.5 pp | BMY |
| FY2012 | +0.9 pp | BMY |
| FY2011 | +11.5 pp | BMY |
| FY2010 | +21.0 pp | BMY |
| FY2009 | +15.6 pp | BMY |
| FY2008 | +2.0 pp | BMY |
| FY2007 | +4.7 pp | BMY |
The higher net margin has changed hands between BMY and MRK over this period.
19 of 19 comparable fiscal years — a year missing data on either side is not counted.
Standard deviation, each side
BMY's net margin has been more volatile than MRK's over the 19 comparable fiscal years — 17.1 percentage points of standard deviation against 11.4.
19 of 19 comparable fiscal years — a year missing data on either side is not counted.
Year by year
The lead in net margin changed hands between BMY and MRK over these 19 fiscal years — BMY led in 10 and MRK in 9.
19 of 19 comparable fiscal years — a year missing data on either side is not counted.
Standard deviation, each side
BMY's return on equity has been more volatile than MRK's over the 18 comparable fiscal years — 24.0 percentage points of standard deviation against 14.4.
18 of 18 comparable fiscal years — a year missing data on either side is not counted.
Year by year
The lead in return on equity changed hands between BMY and MRK over these 18 fiscal years — BMY led in 12 and MRK in 6.
18 of 18 comparable fiscal years — a year missing data on either side is not counted.